Pt(II) Complex with FGFR4 Specificity as a Targeted Drug Conjugate for the Treatment of Hepatocellular Carcinoma
Inorganic Chemistry · 13.04.2026 · 65 (14) · 7833-7847
DOI: 10.1021/acs.inorgchem.6c00037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inorganic Chemistry, online erschienen am 30.03.2026. Verfasst von Libo Cai und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Research Center and School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Carcinoma, Hepatocellular, Receptor, Fibroblast Growth Factor, Type 4, Liver Neoplasms. Die Arbeit nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangsu Province Hi-Tech Key Laboratory for Biomedical Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Pharmaceutical Research Center and School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, China.
ORCID-Profile: Gang Xu, Shaohua Gou
Förderung
- National Natural Science Foundation of China
- Jiangsu Province Hi-Tech Key Laboratory for Biomedical Research
Zitieren
APA
Cai, L., Xu, G., & Gou, S. (2026). Pt(II) Complex with FGFR4 Specificity as a Targeted Drug Conjugate for the Treatment of Hepatocellular Carcinoma. Inorganic Chemistry, 65(14), 7833-7847. https://doi.org/10.1021/acs.inorgchem.6c00037
Vancouver
Cai L, Xu G, Gou S. Pt(II) Complex with FGFR4 Specificity as a Targeted Drug Conjugate for the Treatment of Hepatocellular Carcinoma. Inorganic Chemistry. 2026;65(14):7833-7847. doi:10.1021/acs.inorgchem.6c00037
BibTeX
@article{Cai2026,
author = {Cai, Libo and Xu, Gang and Gou, Shaohua},
title = {Pt(II) Complex with FGFR4 Specificity as a Targeted Drug Conjugate for the Treatment of Hepatocellular Carcinoma},
journal = {Inorganic Chemistry},
year = {2026},
volume = {65},
number = {14},
pages = {7833--7847},
doi = {10.1021/acs.inorgchem.6c00037}
}
EUVIMED